The IMvigor010 trial showed that Signatera-guided treatment with Tecentriq improved disease-free survival and overall ...

Seborrheic dermatitis is linked to other epithelial barrier diseases, supporting the epithelial barrier theory as a shared ...

NDA submission expected in early Q1 2026 for expanded usage of IGALMI® in home setting based on positive data from the ...

Try an experiment. Next time you are in a room with someone, ask them to name everything in the room. Only certain kinds of people will say “air” or “light.” For most people, those are just givens, ...

Over the last decade, there's been growing evidence that people can have TB without having any symptoms. But there is still much uncertainty over how such asymptomatic TB functions in the body and how ...

Regarding the Addition of CDK4/6 Inhibitor to Postoperative Endocrine Therapy in Patients With HR-Positive HER2-Negative High-Risk Breast Cancer ...

Q3 2025 Earnings Call November 7, 2025 11:00 AM ESTCompany ParticipantsAl Petrie - Officer of Investor RelationsPaul McKinney - ...

This study investigates how sleep loss and circadian disruption affect whole-organ metabolism in flies (Drosophila melanogaster) and reports that wild-type flies align metabolism in anticipation of ...

Based on the DESTINY-Breast06 phase III trial results demonstrating statistically significant and clinically meaningful progression-free survival benefit in patients treated with Enhertu vs.